• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Landmarks: examining the foundation for GP IIb/IIIa inhibitors in PCI.

出版信息

J Invasive Cardiol. 2002 Dec;14(12):776-9.

PMID:12537005
Abstract
摘要

相似文献

1
Landmarks: examining the foundation for GP IIb/IIIa inhibitors in PCI.
J Invasive Cardiol. 2002 Dec;14(12):776-9.
2
Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.已确诊冠心病患者的管理与预后：欧洲冠状动脉血运重建调查
Eur Heart J. 2005 Jun;26(12):1169-79. doi: 10.1093/eurheartj/ehi238. Epub 2005 Mar 31.
3
Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.糖蛋白IIb/IIIa受体拮抗剂：我们是否忽略了证据？
Indian Heart J. 2005 May-Jun;57(3):201-9.
4
Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use.经皮冠状动脉介入治疗前使用与不使用糖蛋白IIb/IIIa抑制剂时氯吡格雷预处理的疗效和安全性。
Am Heart J. 2008 May;155(5):910-7. doi: 10.1016/j.ahj.2007.11.020. Epub 2008 Feb 21.
5
The evolving role of glycoprotein (GP) IIb/IIIa receptor blockade during percutaneous coronary intervention of saphenous vein bypass grafts.
J Invasive Cardiol. 2004 Sep;16(9):500-3.
6
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.上游糖蛋白IIb/IIIa抑制及冠状动脉支架置入术在不稳定型心绞痛/非ST段抬高型心肌梗死侵入性治疗中的意义：心肌梗死溶栓治疗（TIMI）IIIB试验与应用阿昔单抗治疗心绞痛并确定侵入性或保守性策略治疗费用（TACTICS）-TIMI 18试验的比较
Circulation. 2004 Feb 24;109(7):874-80. doi: 10.1161/01.CIR.0000112604.74713.35. Epub 2004 Feb 2.
7
Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):907-8. doi: 10.1002/ccd.21622.
8
Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE).急性心肌梗死患者接受经皮冠状动脉介入治疗时的支架置入与糖蛋白IIb/IIIa抑制：全球急性冠状动脉事件注册研究（GRACE）的结果
Catheter Cardiovasc Interv. 2003 Nov;60(3):360-7. doi: 10.1002/ccd.10653.
9
Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.在血小板糖蛋白IIb/IIIa受体阻滞剂作用下经桡动脉支架植入进行直接经皮冠状动脉介入治疗后早期出院是可行的。AGGRASTENT试验结果
J Invasive Cardiol. 2005 Oct;17(10):512-7.
10
Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.稳定型和不稳定型冠状动脉疾病经皮冠状动脉介入治疗期间的药物治疗：意大利血管成形术药物评估（IDEA）研究
Ital Heart J. 2005 Feb;6(2):106-18.